Delta Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Delta Investment Management's BMY Position: Q2 2026 in Review
Delta Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 0.15% in Q2 2026, selling an estimated $345 and leaving 3,982 shares worth $229K. The position accounts for 0.04% of the portfolio, ranked #264.
Delta Investment Management first reported a position in BMY in Q2 2019 and has held it in 26 quarters since. The position peaked at $362K in Q4 2019. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Delta Investment Management held 3,982 shares of Bristol-Myers Squibb worth $229K as of Q2 2026.
- Delta Investment Management sold 6 Bristol-Myers Squibb shares in Q2 2026, an estimated $345.
- Bristol-Myers Squibb made up 0.04% of Delta Investment Management's portfolio in Q2 2026, its #264 holding.
- Delta Investment Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 26 quarters since.
- Delta Investment Management's Bristol-Myers Squibb position peaked at $362K in Q4 2019.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Delta Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.